ReviewEcancermedicalscience2017
History of the development of radiotherapy in Latin America.
Review in Ecancermedicalscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Radiotherapy access in Latin America: Socio-economic determinants and equity challenges socio-economic determinants in Latin America for radiotherapy.Clinical and translational radiation oncology · 2026Article
- The effect of photobiomodulation on the radiosensitivity of cancer cells: a literature review.Lasers in medical science · 2025Review
- First-Line (1L) Treatment Decision Patterns and Survival of Hormone Receptor (HR)-Positive/HER2-Negative Advanced Breast Cancer (ABC) Patients in a Latin American (LATAM) Public Institution.Current oncology (Toronto, Ont.) · 2024Article
- Developing an educational "hub": impact of a distance-learning curriculum in a multinational cohort.BMC medical education · 2024Article
- Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.International journal of radiation oncology, biology, physics · 2023Article
- Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.Journal of neurosurgery · 2022Article
- The state of gynecologic radiation therapy in low- and middle-income countries.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2022Review
- Evaluation of mesalazine polymeric conjugate in the treatment of actinic proctitis in rats.Acta cirurgica brasileira · 2021Article
- COVID's Impact on Radiation Oncology: A Latin American Survey Study.International journal of radiation oncology, biology, physics · 2020Article
- Barriers in Latin America for the management of locally advanced breast cancer.Ecancermedicalscience · 2019Review
- Advancing clinical research globally: Cervical cancer research network from Mexico.Gynecologic oncology reports · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiotherapy was the first nonsurgical treatment for malignant tumours and represents one of the oldest disciplines of oncology. In Latin America, as in many parts of the world, the history of modern oncology begins with the implementation of radiation therapy facilities. The development of radiotherapy in Latin America was possible thanks to the seminal work of radiation oncologists in different countries. As a large territory, there is a need to implement modern facilities and equipment, but unfortunately there are disparities in the access and quality of radiotherapy services across Latin America and even within individual countries. In this review, we describe the history, challenges and success in the implementation of radiotherapy and the frustration caused by the lack of facilities in several Latin American countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.